Global Biomarkers Market Professional Survey Report 2016
- QYR596773
- 105 Pages
- June 2016
- Pharmaceuticals
Product types including
Biomarker of exposure
Biomarker of effect
Susceptibility ofbiomarker
The segment applications including
Diagnostics Development
Drug Discovery and Development
Disease Risk Assessment
Other
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
Abbott Laboratories Inc
GE Healthcare Inc
Beckman Coulter, Inc
Roche Diagnostic Limited
Merck & Co, Inc
Bio-Rad Laboratories, Inc
Perkinelmer, Inc
Qiagen N.V
Biosims Technologies
Meso Scale Diagnostics, LLC
Signosis, Inc
Enzo Biochem
Cisbio Bioassays
Siemens Healthcare
Thermo Fisher Scientific, Inc
Epistem Ltd
With 16 top producers.
Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Biomarkers
1.1 Definition and Specifications of Biomarkers
1.1.1 Definition of Biomarkers
1.1.2 Specifications of Biomarkers
1.2 Classification of Biomarkers
1.2.1 Biomarker of exposure
1.2.2 Biomarker of effect
1.2.3 Susceptibility ofbiomarker
1.3 Applications of Biomarkers
1.3.1 Diagnostics Development
1.3.2 Drug Discovery and Development
1.3.3 Disease Risk Assessment
1.3.4 Other
1.4 Industry Chain Structure of Biomarkers
1.5 Industry Overview and Major Regions Status of Biomarkers
1.5.1 Industry Overview of Biomarkers
1.5.2 Global Major Regions Status of Biomarkers
1.6 Industry Policy Analysis of Biomarkers
1.7 Industry News Analysis of Biomarkers
2 Manufacturing Cost Structure Analysis of Biomarkers
2.1 Raw Material Suppliers and Price Analysis of Biomarkers
2.2 Equipment Suppliers and Price Analysis of Biomarkers
2.3 Labor Cost Analysis of Biomarkers
2.4 Other Costs Analysis of Biomarkers
2.5 Manufacturing Cost Structure Analysis of Biomarkers
2.6 Manufacturing Process Analysis of Biomarkers
3 Technical Data and Manufacturing Plants Analysis of Biomarkers
3.1 Capacity and Commercial Production Date of Global Biomarkers Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Biomarkers Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Biomarkers Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Biomarkers Major Manufacturers in 2015
4 Global Biomarkers Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Biomarkers Capacity and Growth Rate Analysis
4.2.2 2015 Biomarkers Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Biomarkers Sales and Growth Rate Analysis
4.3.2 2015 Biomarkers Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Biomarkers Sales Price
4.4.2 2015 Biomarkers Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Biomarkers Gross Margin
4.5.2 2015 Biomarkers Gross Margin Analysis (Company Segment)
5 Biomarkers Regional Market Analysis
5.1 North America Biomarkers Market Analysis
5.1.1 North America Biomarkers Market Overview
5.1.2 North America 2011-2016E Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Biomarkers Sales Price Analysis
5.1.4 North America 2015 Biomarkers Market Share Analysis
5.2 Europe Biomarkers Market Analysis
5.2.1 Europe Biomarkers Market Overview
5.2.2 Europe 2011-2016E Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Biomarkers Sales Price Analysis
5.2.4 Europe 2015 Biomarkers Market Share Analysis
5.3 Japan Biomarkers Market Analysis
5.3.1 Japan Biomarkers Market Overview
5.3.2 Japan 2011-2016E Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Biomarkers Sales Price Analysis
5.3.4 Japan 2015 Biomarkers Market Share Analysis
5.4 China Biomarkers Market Analysis
5.4.1 China Biomarkers Market Overview
5.4.2 China 2011-2016E Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Biomarkers Sales Price Analysis
5.4.4 China 2015 Biomarkers Market Share Analysis
5.5 Southeast Asia Biomarkers Market Analysis
5.5.1 Southeast Asia Biomarkers Market Overview
5.5.2 Southeast Asia 2011-2016E Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Biomarkers Sales Price Analysis
5.5.4 Southeast Asia 2015 Biomarkers Market Share Analysis
5.6 India Biomarkers Market Analysis
5.6.1 India Biomarkers Market Overview
5.6.2 India 2011-2016E Biomarkers Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Biomarkers Sales Price Analysis
5.6.4 India 2015 Biomarkers Market Share Analysis
6 Global 2011-2016E Biomarkers Segment Market Analysis (by Type)
6.1 Global 2011-2016E Biomarkers Sales by Type
6.2 Different Types Biomarkers Product Interview Price Analysis
6.3 Different Types Biomarkers Product Driving Factors Analysis
6.3.1 Biomarker of exposure Biomarkers Growth Driving Factor Analysis
6.3.2 Biomarker of effect Biomarkers Growth Driving Factor Analysis
6.3.3 Susceptibility ofbiomarker Biomarkers Growth Driving Factor Analysis
7 Global 2011-2016E Biomarkers Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Diagnostics Development Biomarkers Growth Driving Factor Analysis
7.3.2 Drug Discovery and Development Biomarkers Growth Driving Factor Analysis
7.3.3 Disease Risk Assessment Biomarkers Growth Driving Factor Analysis
7.3.4 Other Biomarkers Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Biomarkers
8.1 Abbott Laboratories Inc
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Abbott Laboratories Inc 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Abbott Laboratories Inc 2015 Biomarkers Business Region Distribution Analysis
8.2 GE Healthcare Inc
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 GE Healthcare Inc 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 GE Healthcare Inc 2015 Biomarkers Business Region Distribution Analysis
8.3 Beckman Coulter, Inc
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Beckman Coulter, Inc 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Beckman Coulter, Inc 2015 Biomarkers Business Region Distribution Analysis
8.4 Roche Diagnostic Limited
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Roche Diagnostic Limited 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Roche Diagnostic Limited 2015 Biomarkers Business Region Distribution Analysis
8.5 Merck & Co, Inc
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Merck & Co, Inc 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Merck & Co, Inc 2015 Biomarkers Business Region Distribution Analysis
8.6 Bio-Rad Laboratories, Inc
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Bio-Rad Laboratories, Inc 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Bio-Rad Laboratories, Inc 2015 Biomarkers Business Region Distribution Analysis
8.7 Perkinelmer, Inc
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Perkinelmer, Inc 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Perkinelmer, Inc 2015 Biomarkers Business Region Distribution Analysis
8.8 Qiagen N.V
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Qiagen N.V 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Qiagen N.V 2015 Biomarkers Business Region Distribution Analysis
8.9 Biosims Technologies
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Biosims Technologies 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Biosims Technologies 2015 Biomarkers Business Region Distribution Analysis
8.10 Meso Scale Diagnostics, LLC
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Meso Scale Diagnostics, LLC 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Meso Scale Diagnostics, LLC 2015 Biomarkers Business Region Distribution Analysis
8.11 Signosis, Inc
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Signosis, Inc 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Signosis, Inc 2015 Biomarkers Business Region Distribution Analysis
8.12 Enzo Biochem
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Enzo Biochem 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Enzo Biochem 2015 Biomarkers Business Region Distribution Analysis
8.13 Cisbio Bioassays
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Cisbio Bioassays 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Cisbio Bioassays 2015 Biomarkers Business Region Distribution Analysis
8.14 Siemens Healthcare
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Siemens Healthcare 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Siemens Healthcare 2015 Biomarkers Business Region Distribution Analysis
8.15 Thermo Fisher Scientific, Inc
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Thermo Fisher Scientific, Inc 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Thermo Fisher Scientific, Inc 2015 Biomarkers Business Region Distribution Analysis
8.16 Epistem Ltd
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Epistem Ltd 2015 Biomarkers Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Epistem Ltd 2015 Biomarkers Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Biomarkers Consumption Forecast
9.2.2 Europe 2016-2021 Biomarkers Consumption Forecast
9.2.3 Japan 2016-2021 Biomarkers Consumption Forecast
9.2.4 China 2016-2021 Biomarkers Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Biomarkers Consumption Forecast
9.2.6 India 2016-2021 Biomarkers Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Biomarkers Marketing Model Analysis
10.1 Biomarkers Regional Marketing Model Analysis
10.2 Biomarkers International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Biomarkers by Regions
10.4 Biomarkers Supply Chain Analysis
11 Consumers Analysis of Biomarkers
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Biomarkers
12.1 New Project SWOT Analysis of Biomarkers
12.2 New Project Investment Feasibility Analysis of Biomarkers
13 Conclusion of the Global Biomarkers Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
